Immunotherapy
Here below, you will find a list of all the latest content published on this website on the topic of Cancer Immunology and Immunotherapy. The content is published in chronological order. Find out more about our content categorisation .
-
« Previous
- 1
- 2
- ...
- 88
-
Next »
- Pembrolizumab–Trastuzumab May Offer PANACEA For Trastuzumab-Resistant Breast Cancer
- PD-1 Inhibitor Efficacy Predicted By Immune-Related Adverse Events
- Ibrutinib Plus Nivolumab May Be ‘Promising’ For CLL Richter’s Transformation
- Combination Therapy
- Participant Clinical Case Discussion: Exceptional Responder to Immunotherapy - A Rare Case of Post HSCT DLBCL Relapse Responding to Nivolumab
- CAR T-Cell Therapy
- Participant Clinical Case Discussion: Metastatic Melanoma with Pneumonitis
- Participant Clinical Case Discussion:
- Duration of Therapy
- Participant Clinical Case Discussion: Metastatic Castration Resistant Prostate Cancer with Complete Response After 6 Cycles of Immunotherapy
- Hodgkin’s Lymphoma and Other Haematological Malignancies
- Advanced Urinary Cancer (Renal and Bladder)
- Participant Clinical Case Discussion: Duration Response of Pembrolizumab in MSI Positive BRAF V600E Mutant Metastatic Ceacal Cancer
- Participant Clinical Case Discussion: Hepatocellular Carcinoma and Immunotherapy
- Participant Clinical Case Discussion: Impressive Response to Nivolumab in a Metastatic Gastric Cancer Patient
- Participant Clinical Case Discussion: PD-L1 - 100%: A Rare Entity
- Colorectal Cancer
- Oesophageal and Gastric Cancer
- Hepatocellular Carcinoma (HCC)
- Immune Related Toxicities and Management
- Biomarkers: PD-L1
- Non-Small-Cell Lung Cancer
- Assessment of Efficacy
- Melanoma Advanced and Adjuvant
- History of Cancer Immunology/Immunotherapy
-
« Previous
- 1
- 2
- ...
- 88
-
Next »